Cardiac_disturbances_during_the_administration_of_taxol._The_clinical_development_of_taxol,_a_new_antimicrotubule_agent_with_a_unique_mechanism_of_cytotoxic_action,_has_proceeded_slowly_due_to_serious_hypersensitivity_reactions_(HSRs)_and_shortages_in_its_supply._Nevertheless,_large-scale_phase_II_trials_have_been_initiated_as_taxol_has_recently_demonstrated_impressive_activity_in_advanced_and_cisplatin-refractory_ovarian_carcinoma._Furthermore,_the_incidence_of_HSRs_has_been_reduced_substantially_with_premedications_and_modifications_in_the_administration_schedule._However,_various_manifestations_of_potential_cardiotoxicity_have_been_observed_in_several_patients_who_participated_in_four_phase_I_and_II_studies_of_taxol._Asymptomatic_bradycardia_has_occurred_in_a_high_proportion_of_patients,_including_29%_of_ovarian_cancer_patients_who_were_treated_with_maximally_tolerated_doses_of_taxol_in_a_phase_II_study._More_profound_cardiac_disturbances,_including_a_range_of_atrioventricular_conduction_blocks,_left_bundle_branch_block,_ventricular_tachycardia_(VT),_and_manifestations_of_cardiac_ischemia,_have_been_observed_in_seven_of_140_patients_(5%)_who_received_taxol._Descriptions_of_these_events_are_presented_in_this_report_to_alert_investigators_to_the_potential_for_these_adverse_effects._Although_these_disturbances_did_not_result_in_serious_sequelae_in_most_patients,_investigators_should_continue_to_maintain_a_high_degree_of_caution_until_precise_risk_factors,_frequency,_and_clinical_significance_of_these_adverse_cardiac_effects_are_determined.